Described herein are pharmaceutical packaging systems which prevent oxidative degradation of morphine, hydromorphone, promethazine as well as other oxygen-delicate medications, such units including a syringe by having an oxygen permeable tip cap, a hermetically sealed oxygen barrier blister packaging with pretty lower permeability to oxygen and com